Ftse Mib
33.220,31
-0,29%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
64.842,73
-0,19%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Knight Therapeutics Inc (GUD) Knight Therapeutics Inc (GUD) Notizie

Knight Therapeutics Inc

GUD
5,45
0,02 (0,37%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Toronto
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
09/5/202413:30GLOBEKnight Therapeutics Enters into Exclusive Supply and..
09/5/202400:32GLOBEKnight Therapeutics Inc. announces voting results from the..
07/5/202413:30GLOBEKnight to Present at the 2024 RBC Capital Markets Global..
02/5/202413:30GLOBENotice of Knight Therapeutics' First Quarter 2024 Results..
09/4/202413:30GLOBEKnight to Present at the 2024 Bloom Burton & Co. Healthcare..
28/3/202416:03GLOBEKnight Therapeutics Inc. ranks on The Globe and Mail’s..
21/3/202412:30GLOBEKnight Therapeutics Reports Fourth Quarter and Year-End 2023..
14/3/202412:30GLOBENotice of Knight Therapeutics' Fourth Quarter and Year End..
29/2/202413:30GLOBEKnight Therapeutics Announces Launch of Minjuvi® in Brazil
28/2/202413:30GLOBEKnight Therapeutics Inc. Celebrates its First Decade of..
21/2/202423:30GLOBEKnight Therapeutics Announces Regulatory Submission of..
06/2/202413:30GLOBEKnight Therapeutics Announces Launch of Bijuva® in Canada
25/1/202413:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
04/1/202413:30GLOBEKnight Therapeutics Announces Product Launch for IMVEXXY® in..
19/12/202313:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
09/11/202313:30GLOBEKnight Therapeutics Reports Third Quarter 2023 Results
02/11/202312:30GLOBENotice of Knight Therapeutics' Third Quarter 2023 Results..
16/10/202313:30GLOBEKnight Therapeutics Announces CMED Price Approval of..
10/10/202322:45GLOBEKnight Therapeutics Announces Regulatory Submission of..
02/10/202322:30GLOBEKnight Therapeutics Inc. places No. 90 on The Globe and..
10/8/202317:00APSTrading For This Specialty Pharma Company is up Following..
10/8/202313:30GLOBEKnight Therapeutics Reports Second Quarter 2023 Results
04/8/202302:32GLOBENotice of Knight Therapeutics' Second Quarter 2023 Results..
12/7/202313:30GLOBEKnight Announces Normal Course Issuer Bid
Apertura: 5,46 Min: 5,42 Max: 5,55
Chiusura: 5,43

La tua Cronologia

TSX
GUD
Knight Therapeutics
EU
BNPHW
BNPP 2.67% until 13mar2030
NASDAQI
B5010GI
OMX Baltic Construction ...
LSE
44JR
Barclays 23
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network